ATC codes:
P01BC01
EMLc
Indication
Malaria due to Plasmodium falciparum
ICD11 code:
1F40
Medicine type
Chemical agent
List type
Core
(EML)
(EMLc)
(EMLc)
Additional notes
For use only in the management of severe malaria
Formulations
Parenteral > General injections > IV:
300 mg per mL in 2 mL ampoule (hydrochloride) solution for infusion ;
60 mg per mL in 2 mL ampoule (hydrochloride) solution for infusion
(EMLc)
EML status history
Sex
All
Age
Also recommended for children
Therapeutic alternatives
The recommendation is for this specific medicine
Patent information
Patents have expired in most jurisdictions
Read more
about patents.
Summary of evidence and Expert Committee recommendations
Following the review of the age-appropriateness of formulations on the EMLc, the Expert Committee recommended:
- the addition of quinine solution for infusion 60 mg/mL to the EMLc for use in the management of severe malaria;
- the deletion of quinine tablet 300 mg from the EML and EMLc;
- an amendment to the footnote to specify use only in the management of severe malaria;
- to modify the formulation descriptions to better describe the available dosage forms.